共查询到19条相似文献，搜索用时 363 毫秒
1.
鸭肠炎病毒(Duck enteritis virus, DEV),又称为鸭瘟病毒,是一种只感染雁形目禽类的疱疹病毒。DEV具有基因组大、非必需基因多、能插入外源基因的容量大、遗传稳定等优点,其庞大而复杂的基因组为外源基因提供了诸多可插入位点,以DEV为载体,成功表达了禽流感病毒HA蛋白[1]、鸭病毒性肝炎病毒VP0蛋白[2]、鸭坦布苏病毒E基因[3]以及鹅细小病毒VP2蛋白[4]。构建重组DEV的重要一步是将报告基因插入到基因组中,目前常用的报告基因有绿色荧光蛋白(GFP)、增强型绿色荧光蛋白(EGFP)、红色荧光蛋白(RFP)以及LacZ报告基团。本研究用RFP报告基团插入DEV UL2基因中,获得表达红色荧光的重组病毒,一步生长曲线表明,RFP对DEV的生长无影响;连续传代12代,RFP能够稳定表达,为DEV载体研究奠定基础。 相似文献
2.
为探寻伪狂犬病毒（Pseudorabies virus，PRV）基因缺失株rPRV-bc-8基因组UL4-UL3基因间区域是否可作为外源基因的插入位点，在实验室已构建的含有增强型绿色荧光蛋白（Enhance Green fluorescent protein，EGFP）基因的转移质粒pMD-US6+7-EGFP-US2的基础上，通过DNA体外分子克隆技术将UL4序列替换左同源臂US6+7序列，UL3序列替换右同源臂US2序列，并将PolyA引入转移质粒，得到转移质粒pMD-UL4-EGFP-UL3。利用脂质体转染法将转移质粒pMD-UL4-EGFP-UL3与亲本毒rPRV-bc-8共转染PK-15细胞，经蚀斑纯化成功得到一株能够稳定表达EGFP基因的重组伪狂犬病毒rPRV-UL4-EGFP-UL3。通过倒置荧光显微镜观察以及PCR鉴定确定EGFP基因已成功插入到伪狂犬基因组的UL4-UL3之间，并通过细胞传代试验分析得到重组毒的遗传稳定性良好。通过体外增殖试验分析得到重组病毒rPRV-UL4-EGFP-UL3在细胞内的增殖速度较快，接种后12 h内滴度始终高于亲本毒rPRV-bc-8，接种后40 h达到最高滴度108.3 TCID50/mL，与亲本毒的最高滴度接近，但是最高滴度的出现时间晚于亲本毒，并且在达到平台期后病毒滴度下降的比亲本毒快。通过对病毒培养液中荧光蛋白浓度进行测定，结果显示在接种后56 h时荧光蛋白浓度达到最高值4793.9 ng/mL，之后进入平台期。综上结果表明构建的重组病毒具有良好的遗传稳定性及体外复制能力，并且外源基因EGFP在此位点具有良好的表达效果，为进一步相关重组病毒的构建奠定了基础。 相似文献
3.
构建表达HP-PRRSV河南分离株HN1 N蛋白基因的siRNA重组伪狂犬病病毒3株,将其感染PK-15细胞,在细胞水平上评价重组伪狂犬病病毒介导的siRNA对N蛋白表达的抑制效果.PCR扩增带CMV-siRNA-poly(A)片段和新霉素基因,通过酶切将CMV-siRNA-poly(A)片段和新霉素基因分别插入伪狂犬病病毒转移载体pUSKBH中,构建重组伪狂犬病病毒通用转移载体pUsiRNA.分别用BamH Ⅰ和HindⅢ酶切pUsiRNA,回收后与HP-PRRSV河南分离株HN1 N蛋白基因的3个siRNA分子连接,构建表达N蛋白基因siRNA的重组伪狂犬病病毒表达载体.将鉴定正确的重组伪狂犬病病毒表达载体与伪狂犬病病毒DNA共转染PK-15细胞,经同源重组及噬斑纯化获得表达N蛋白基因siRNA的重组伪狂犬病病毒株,应用PCR及Southern blot鉴定重组病毒.将HN1株N蛋白基因的真核表达质粒pAcGFP1-N转染PK-15,经筛选获得稳定表达N蛋白基因的细胞.将鉴定正确的表达N蛋白基因siRNA的重组伪狂犬病病毒接种于稳定表达N蛋白基因的细胞,利用绿色荧光蛋白基因及半定量RT-PCR检测重组伪狂犬病病毒介导的N蛋白基因siRNA对N蛋白表达的抑制效果.结果显示,PCR扩增到的CMV-siR-NA-poly(A)片段约为0.7kb,新霉素基因约1.5kb.经酶切、PCR及测序鉴定,构建了表达siRNA的通用伪狂犬病病毒转移载体pUsiRNA.经PCR及Southern blot检测,获得了3株表达HP-PRRSV河南分离株HN1 N蛋白基因siRNA的重组伪狂犬病病毒gG-/siRNAN1、gG-/siRNAN2和gG-/siRNAN3;经荧光显微镜观察和半定量RT-PCR检测表明,重组伪狂犬病病毒介导的N蛋白基因siRNA能够显著抑制N蛋白在PK-15细胞中表达,其中gG-/siR-NAN2抑制效果最好.这为深入研究N蛋白基因siRNA抑制HP-PRRSV复制奠定基础,并为HP-PRRSV的防制提供新的思路. 相似文献
4.
[目的]旨在通过构建秦川牛丙酮酸脱氢酶β亚基(Pyruvate dehydrogenase β subunit,PDHB)基因的重组腺病毒载体,为研究PDHB基因在牛前体脂肪细胞分化过程中的功能做准备。[方法]根据牛PDHB基因mRNA序列(GenBank Accession No.NM_001035435)设计引物,克隆该基因的编码区(Coding Sequence, CDS)序列。测序验证后将其重组到穿梭载体pAdTrack-CMV上,经PmeⅠ线性化后,转化到含有pAdEasy-1腺病毒骨架载体的E. coli BJ5183感受态细胞中进行同源重组,以获得重组质粒pAd-PDHB。再将经PacⅠ酶切线性化的pAd-PDHB转染到HEK 293A细胞中,进行病毒包装并扩增高滴度病毒Ad-PDHB,绿色荧光蛋白(GFP)标记法测定病毒滴度。将高浓度的Ad-PDHB病毒感染牛肌内前体脂肪细胞,实时荧光定量PCR(qRT-PCR)检测PDHB的表达量。[结果]经测序验证,本实验克隆获得的牛PDHB基因CDS与数据库GenBank收录的序列一致。将PDHB基因CDS与穿梭载体pAdTrack-CMV重组并转染HEK 293A细胞后成功获得了重组腺病毒Ad-PDHB,其滴度为1.66×109 PFU.mL-1。腺病毒Ad-PDHB侵染牛肌内前体脂肪细胞后,PDHB在mRNA的表达水平比对照组高25.5倍。[结论]成功克隆了秦川牛PDHB基因并构建了重组腺病毒质粒pAd-PDHB,并获得能够在牛肌内前体脂肪细胞中过表达PDHB基因的高滴度重组腺病毒Ad-PDHB。 相似文献
5.
为筛选能够有效抑制J亚型禽白血病病毒(ALV-J)复制的siRNA,本研究根据ALV的pol基因保守序列设计合成5对shRNA序列,并将其分别克隆至pcDNATM6.2-GW/EmGFP-miR载体中,构建siRNA表达重组质粒,分别为pcDNA-sh-po1711、pcDNA-sh-po1814、pcDNA-sh-po11016、pcDNA-sh-po11915和pcDNA-sh-po12516.将重组质粒分别转染DF-1细胞6 h后,以100TCID50的ALV-J感染细胞,并利用IFA、western blot和real-timePCR方法评价其对ALV-J复制的抑制效果.IFA和western blot检测结果表明:其中pcDNA-sh-po1711、pcDNA-sh-po1814和pcDNA-sh-po12516可以有效抑制病毒囊膜蛋白的表达.Real-time PCR结果显示:与阴性对照和空载体对照相比,这3种siRNA在mRNA水平对ALV-J的抑制率达29%～86%.本研究在细胞水平上筛选的siRNAs可作为候选siRNAs,为抗鸡ALV-J的研究奠定基础. 相似文献
6.
为原核表达禽网状内皮组织增生症病毒(REV)env蛋白及制备抗env蛋白的高效价多克隆抗体,本研究以pMD18T-env(HLJR0901株)为模板,扩增得到REV的env全长基因,将其克隆于pET-32a(+)中。将阳性重组质粒pET-env转化E.coli BL21(DE3)感受态细胞,经IPTG诱导表达。利用亲和层析纯化重组蛋白,复性后免疫BALB/c小鼠,制备抗env多克隆血清。SDS-PAGE及western blot结果表明,env基因以融合蛋白形式获得正确表达,相对分子质量约为84ku,表达产物具有良好免疫原性;IFA结果显示,制备的抗env多克隆血清能与REV野毒株特异性反应;ELISA效价达到1∶105以上。该研究为REV的检测及env蛋白的深入研究奠定了基础。 相似文献
7.
为探讨口蹄疫病毒多基因及猪α干扰素（IFN-α）基因共表达真核质粒进入临床试验的可行性,本试验用PCR方法扩增了口蹄疫病毒P12A3C及部分2B基因（P12X3C）和猪IFN-α基因,克隆到真核表达载体pBudCE4.1中,经双酶切鉴定后,将重组质粒pBudCE4.1-P12X3C-IFN-α转染BHK-21细胞中,观察目的基因的表达,并将重组质粒免疫豚鼠,检测豚鼠的血清抗体水平、中和抗体滴度及T淋巴细胞增殖情况。结果显示,经酶切鉴定及DNA序列分析成功构建了重组质粒pBudCE4.1-P12X3C-IFN-α,转染BHK-21细胞后,通过Western blotting、间接免疫荧光试验鉴定证实重组质粒能有效表达。ELISA结果显示,重组质粒pBudCE4.1-P12X3C-IFN-α比重组质粒pBudCE4.1-P12X3C能诱导机体产生更高水平的抗口蹄疫病毒的血清抗体,且中和抗体滴度也高于重组质粒pBudCE4.1-P12X3C组。MTT法检测结果表明,重组质粒pBudCE4.1-P12X3C-IFN-α组淋巴细胞增殖可达15%,而重组质粒pBudCE4.1-P12X3C组则为11%。攻毒后重组质粒pBudCE4.1-P12X3C-IFN-α组和灭活疫苗组保护率达100%,高于重组质粒pBudCE4.1-P12X3C组的80%。本试验成功构建了重组质粒pBudCE4.1-P12X3C-IFN-α,猪IFN-α作为佐剂可有效辅助口蹄疫DNA疫苗提高动物体内的免疫反应。 相似文献
8.
《动物医学进展》2021,42(1)
为了构建靶向突触分化诱导基因1(SynDIG1)的shRNA慢病毒表达载体,设计出SynDIG1的siRNA的靶点序列,并合成含干扰序列的双链DNA发卡结构shRNA,合成的Oligo经过退火分别与双酶切处理后的pLKO.1-GFP载体连接。将构建的重组质粒pLKO.1-GFP-SynDIG1 shRNA转化到DH5α感受态细菌中,过夜培养后挑选阳性克隆子,扩增后提取DNA进行质粒测序,得到两个序列正确的重组质粒。用这些重组质粒转染HEK293T细胞以及大鼠海马神经元细胞,蛋白免疫印迹及细胞免疫荧光检测SynDIG1 shRNA对外源性和内源性SynDIG1表达的敲减作用。进一步用重组质粒转染HEK293T细胞产生慢病毒颗粒,用病毒颗粒感染DIV2和DIV14的神经细胞,免疫印迹检测SynDIG1的表达。结果表明这两个重组质粒均能够有效地抑制外源性和内源性SynDIG1的表达,对HEK293T中瞬时表达的SynDIG1敲减率达到75%,其慢病毒颗粒感染对早期神经细胞中内源性SynDIG1的表达抑制也很明显。用pLKO.1-GFP成功构建了能够有效抑制外源性和内源性SynDIG1表达的重组质粒,为探讨RNA干扰技术抑制神经细胞SynDIG1基因表达的相关研究奠定基础,为研究SynDIG1基因在神经传导和突触发育及其可塑性调节中的作用提供了有力工具。 相似文献
9.
禽白血病病毒亚群重组囊膜蛋白基因的表达效果 总被引：1，自引：0，他引：1
用ELISA法测定了重组杆状病毒rBac-4817env感染的Sf9细胞中重组囊膜蛋白基因的表达效果。用特异性抗禽白血病病毒J型群（ALV-J）单克隆抗体JE9荧光染色证明了重组病毒能够在感染的Sf9细胞中表达ALV-J的env基因；糖基化抑制试验的结果表明，Sf9细胞表达的env基因产物是一种糖基化蛋白。不同量的重组病毒感染细胞与基因产物的表达产量无正相关，然而当每个细胞感染的病毒量2-800个时，表达产量相对较好。表达产物以感染后72-96h较高，并随着感染时间的延长，分泌到细胞外的重组基因产物有所增加，但在120h后，表达产物分解增加。研究结果对今后获取大量的基因的产物，并对其特性进一步研究奠定了基础。 相似文献
10.
为筛选鸡马立克氏病病毒(MDV)gI、gE基因特异性siRNA,本研究以鸡胚成纤维细胞(CEF)的DNA为模板,扩增禽源cU6-3启动子序列,并合成针对gI和gE基因各5个靶位点的10条shRNA序列.通过重叠PCR将cU6-3启动子与shRNA融合扩增制备shRNA表达盒,将制备的shRNA表达盒分别与重组质粒pEGFP-gI或pEGFP-gE共转染CEF细胞,并根据荧光显微镜观察和流式细胞仪检测结果评价siRNA抑制融合荧光蛋白表达的效率.结果表明,gI和gE基因的抑制效率为10%～80%.分别将其中抑制效率最高的一条shRNA插入pGEM-T载体中构建重组表达质粒pcU6-shgI735和pcU6-shgE936,通过不同细胞系稳定干扰试验和抑制病毒复制试验评价其干扰活性.结果显示,pcU6-shgI735和pcU6-shgE936能够明显抑制融合蛋白的表达及MDV在CEF细胞中的增殖,并且禽源U6启动子构建的表达盒在禽源细胞(DF1)中的活性比在哺乳动物细胞(Vero、MDCK)的活性高1.21～1.45倍.本研究鉴定获得了gI和gE基因的特异性siRNA,筛选出能够抑制MDV复制的靶位点,为MDV基因的功能和抗MDV病毒研究奠定了基础. 相似文献
11.
Wei Cong Hong Jin Chengda Jiang Weiyao Yan Mingqiu Liu Jiulian Chen Xiaoping Zuo Zhaoxin Zheng 《Veterinary research》2010,41(3)
In this study, specific sequences within three genes (3D, VP4 and 2B) of the foot-and-mouth disease virus (FMDV) genome were determined to be effective RNAi targets. These sequences are highly conserved among different serotype viruses based on sequence analysis. Small interfering RNA (siRNA)-expressing plasmids (p3D-NT19, p3D-NT56, pVP4-NT19, pVP4-NT65 and p2B-NT25) were constructed to express siRNA targeting 3D, VP4 and 2B, respectively. The antiviral potential of these siRNA for various FMDV isolates was investigated in baby hamster kidney (BHK-21) cells and suckling mice. The results show that these siRNA inhibited virus yield 10- to 300-fold for different FMDV isolates of serotype O and serotype Asia I at 48 h post infection in BHK-21 cells compared to control cells. In suckling mice, p3D-NT56 and p2B-NT25 delayed the death of mice. Twenty percent to 40% of the animals that received a single siRNA dose survived 5 days post infection with serotype O or serotype Asia I. We used an attenuated Salmonella choleraesuis (C500) vaccine strain, to carry the plasmid that expresses siRNA directed against the polymerase gene 3D (p3D-NT56) of FMDV. We used guinea pigs to evaluate the inhibitory effects of recombinant S. cho (p3D-NT56/S. cho) on FMDV infection. The results show that 80% of guinea pigs inoculated with 109 CFU of p3D-NT56/S. cho and challenged 36 h later with 50 ID50 of homologous FMDV were protected. We also measured the antiviral activity of p3D-NT56/S. cho in swine. The results indicate that 100% of the animals treated with 5 × 109 CFU of p3D-NT56/S. cho were protected in 9 days. 相似文献
12.
In this study, the proliferation of goat pox virus (GPV) was researched using the recombinant GPV of TK gene insertion inactivation. Different length DNA fragments X1, X2, X3 and X4 were inserted into the transfer plasmid pTKfpgigp to constructed the recombinant transfer plasmids and these plasmids were transfected into lamb testis cells infected GPV. Recombinant GPVs of TK gene inactivation by inserting foreign DNA fragment of 2 800, 4 000, 5 200 and 7 700 bp,respectively, were generated via homologous recombination. Four recombinant GPVs (rGPV/tk-) were obtained by selective culture and the virus titer were mensurated by 50% tissue culture infective dose. The results showed that the rGPV/tk- virus titers were decreased obviosuly which was comparable with the wild type GPV AV41. Furthermore, the virus titer of the recombinant virus was decreased more obviously with the extension of the foreign DNA fragment. The result indicated that the proliferation of the GPV was depressed when GPV TK gene was deficient. 相似文献
13.
为了研究山羊痘病毒TK基因功能缺失对其增殖的影响,同源重组构建TK基因缺失型重组山羊痘病毒,检测其增殖特性。试验在通用转移质粒pTKfpgigp内插入不同长度的X1~X4片段,构建了4个重组转移质粒;重组质粒转染已感染山羊痘病毒的羔羊睾丸细胞,经同源重组产生4株TK基因缺失型重组山羊痘病毒rGPV/tk－,其TK基因内分别插入了长度约为2 800、4 000、5 200、7 700 bp的外源DNA片段;筛选纯化重组毒株,测定rGPV/tk－病毒滴度。结果显示,TK基因失活后,rGPV/tk－病毒滴度明显降低;随着插入DNA片段的延长,重组毒株的病毒滴度下降程度更加明显。研究表明,TK基因功能的缺失对山羊痘病毒的增殖具有一定的抑制作用,并与外源DNA的长度具有相关性。 相似文献
14.
本研究从疑似牛病毒性腹泻病毒(bovine viral diarrhea virus,BVDV)感染牛的分泌物与排泄物中分离鉴定1株牛病毒性腹泻病毒,并进行E2基因序列分析。结果表明,分离株病毒命名为JN株;Reed-Muench法测定分离株病毒TCID50为10-7.5/0.1 mL;病毒中和试验结果表明,BVDV JN分离株可被BVDV阳性血清特异性中和,而不能被BVDV阴性血清中和;分离株病毒E2基因序列测序结果表明,该分离毒株属于BVDVⅠa亚型。 相似文献
15.
为鉴定猪传染性胃肠炎病毒(porcine transmissible gastroenteritis virus,TGEV)NSP8蛋白的抗原表位,本研究对GST-NSP8重组蛋白进行了原核表达,并用纯化后的重组蛋白免疫6周龄BALB/c小鼠,取免疫小鼠脾脏,采用常规杂交瘤细胞融合方法,经3次亚克隆后制备了1株稳定分泌抗NSP8蛋白的单克隆抗体杂交瘤细胞株。分泌的单克隆抗体亚类鉴定其重链为IgG1型,轻链为κ链;杂交瘤细胞培养上清的效价为1∶3 200。Western blotting试验结果表明该单克隆抗体能识别原核及真核表达的NSP8重组蛋白。利用截短表达的方法对NSP8蛋白进行抗原表位的鉴定,初步确定了单克隆抗体针对的抗原表位序列为31SPQILKQLTKAFNIAKSDFEREASV55。本研究制备的单克隆抗体及对抗原表位的鉴定,为TGEV NSP8蛋白相关功能的研究奠定了基础。 相似文献
16.
Wei Ouyang Jin-rong Ma Yong-qiang Wang Li-ting Qin Jie-yuan Jiang Hong-jie Fan Xiao-mei Wang Yong-shan Wang 《Veterinary microbiology》2013
Infectious bursal disease virus (IBDV) causes a highly contagious and immunosuppressive disease in young chickens and results in considerable economic losses for the poultry industry. To suppress the replication of IBDV, two short hairpin RNAs (shRNAs) were designed for targeting the VP1 and VP2 genes of IBDV. Recombinant plasmids carrying each shRNA or two shRNAs were constructed based on vector pSilencer2.1-U6 in which the human U6 promoter was replaced with chicken U6 promoter. In chicken embryo fibroblasts, transfection with these shRNA plasmids 24 h before infection with IBDV B87 reduced 50% tissue culture infectious doses (TCID50) from 108.75 TCID50/0.1 mL to 103.75–101.0 TCID50/0.1 mL. In 10-day old specific pathogen-free (SPF) chicken embryos, incubation with a mixture of IBDV B87 and a shRNA plasmid via the allantoic cavity resulted in 100% mortality and high IBDV virus titer in the control group but 25–0% mortality and near normal embryo development in the specific shRNA groups; additionally, IBDV VP1 and VP2 mRNA levels were reduced by 72–95% in the shRNA groups as compared with the control groups. When challenged with a virulent strain IBDV GX8/99, 14-day-old chickens pre-treated with the single shRNA plasmids or the dual shRNA plasmid showed approximately 70% or 90% survival at 5 days post-challenge while those pre-treated with control plasmid or saline had less than 5% survival. The current study suggests that two IBDV shRNAs expressed by a plasmid under chicken U6 promoter could effectively and synergistically reduce IBDV replication in vitro and in vivo. 相似文献
17.
猪乙型脑炎病毒E基因的克隆与序列分析 总被引：2，自引：1，他引：1
根据GenBank中猪乙型脑炎病毒SA14-14-2基因序列设计2对引物,从分离的猪源乙型脑炎病毒SD-001株的细胞培养物中扩增出包括E基因全长的两段基因,将扩增的目的片段进行克隆与序列分析。结果表明,所克隆的E基因编码结构域（Domain）区段与SA14-14-2、P3、Beijing-1等毒株的核苷酸与氨基酸序列同源性分别达97.2%与96.8%以上,属于Ⅲ型乙型脑炎病毒,与疫苗株SA14-14-2的Domain区相比,共有8个氨基酸位点变异。 相似文献
18.
运用PCR技术扩增出伪狂犬病病毒糖蛋白gD基因,将该基因定向克隆于真核表达载体pcDNA3.1+、pCI-neo中,命名重组质粒为pcD-gD、pCI-gD.以小鼠为动物模型,对构建的基因疫苗进行免疫原性的初步评价.为了证明细胞因子是否能增强基因疫苗的免疫效力,本试验用IL-15的表达质粒联合pcD-gD、pCI-gD免疫.结果表明,重组质粒组主要提高细胞免疫水平,特别是联合组中的CD8~+相对其他组别较高.重组质粒在体液免疫方面没有表现出优势,抗体滴度达不到阳性对照组的水平,但是整个抗体水平相对稳定,提示DNA疫苗诱导的抗体维持时间较长. 相似文献
19.
F.S. Campos D. Dezen D.A. Antunes H.F. Santos T.S. Arantes A. Cenci F. Gomes F.E.S. Lima W.M.E.D. Brito H.C.K. Filho H.B.C.R. Batista F.R. Spilki A.C. Franco F.A.M. Rijsewijk P.M. Roehe 《Veterinary microbiology》2011
Bovine herpesvirus type 5 (BoHV-5) is the causative agent of bovine herpetic encephalitis. In countries where BoHV-5 is prevalent, attempts to vaccinate cattle to prevent clinical signs from BoHV-5-induced disease have relied essentially on vaccination with BoHV-1 vaccines. However, such practice has been shown not to confer full protection to BoHV-5 challenge. In the present study, an inactivated, oil adjuvanted vaccine prepared with a recombinant BoHV-5 from which the genes coding for glycoprotein I (gI), glycoprotein E (gE) and membrane protein US9 were deleted (BoHV-5 gI/gE/US9−), was evaluated in cattle in a vaccination/challenge experiment. The vaccine was prepared from a virus suspension containing a pre-inactivation antigenic mass equivalent to 107.69 TCID50/dose. Three mL of the inactivated vaccine were administered subcutaneously to eight calves serologically negative for BoHV-5 (vaccinated group). Four other calves were mock-vaccinated with an equivalent preparation without viral antigens (control group). Both groups were boostered 28 days later. Neither clinical signs of disease nor adverse effects were observed during or after vaccination. A specific serological response, revealed by the development of neutralizing antibodies, was detected in all vaccinated animals after the first dose of vaccine, whereas control animals remained seronegative. Calves were subsequently challenged on day 77 post-vaccination (pv) with 109.25 TCID50 of the wild-type BoHV-5 (parental strain EVI 88/95). After challenge, vaccinated cattle displayed mild signs of respiratory disease, whereas the control group developed respiratory disease and severe encephalitis, which led to culling of 2/4 calves. Searches for viral DNA in the central nervous system (CNS) of vaccinated calves indicated that wild-type BoHV-5 did not replicate, whereas in CNS tissues of calves on the control group, viral DNA was widely distributed. BoHV-5 shedding in nasal secretions was significantly lower in vaccinated calves than in the control group on days 2, 3, 4 and 6 post-challenge (pc). In addition, the duration of virus shedding was significantly shorter in the vaccinated (7 days) than in controls (12 days). Attempts to reactivate latent infection by administration of dexamethasone at 147 days pv led to recrudescence of mild signs of respiratory disease in both vaccinated and control groups. Infectious virus shedding in nasal secretions was detected at reactivation and was significantly lower in vaccinated cattle than in controls on days 11–13 post-reactivation (pr). It is concluded that the inactivated vaccine prepared with the BoHV-5 gI/gE/US9− recombinant was capable of conferring protection to encephalitis when vaccinated cattle were challenged with a large infectious dose of the parental wild type BoHV-5. However, it did not avoid the establishment of latency nor impeded dexamethasone-induced reactivation of the virus, despite a significant reduction in virus shedding after challenge and at reactivation on vaccinated calves. 相似文献